Magnet Biomedicine

About:

Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.

Website: https://magnetbio.com

Top Investors: ARCH Venture Partners, Newpath Management

Description:

Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues. Magnet Biomedicine leverages its TrueGlue discovery platform, which utilizes the latest advancements in human biology and proteomics. This platform identifies specialized adhesives optimized to maximize therapeutic effectiveness while delivering significant advantages, such as enhancing selectivity, fostering biological synergy on specific targets, and addressing previously challenging-to-target proteins. Magnet Biomedicine is actively harnessing the vast untapped potential of TrueGlues to address various disease areas and biological mechanisms, including but not limited to cancer, cardiovascular disease, and immune disorders.

Total Funding Amount:

$50M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)magnetbio.com

Founders:

Brian Safina

Number of Employees:

11-50

Last Funding Date:

2023-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai